Clovis Oncology (NASDAQ: CLVS)
Some price data may be temporarily unavailable.
Clovis Oncology Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Clovis Oncology Company Info
Clovis Oncology Inc. is a biopharmaceutical company focused on acquiring developing and commercializing innovative anti-cancer agents in the United States Europe and additional international markets.
News & Analysis
Why Clovis Oncology Zoomed 30% Higher Today
The biotech delivers some highly encouraging news on the clinical front.
Why Clovis Oncology Stock Is Sinking Today
The biotech's Q2 financial results are concerning investors today.
Why Clovis Oncology Stock Trounced the Market Today
Investors were cheered by news of a freshly signed supply deal.
Why Clovis Oncology Stock Went Into Retreat Mode This Week
After a massive surge in its share price recently, Clovis Oncology has started to reverse course.
Why Clovis Oncology Stock Is Crushing It Today
Shareholders didn't give short-sellers what they wanted.
Why Clovis Oncology Shares Jumped 158.9% in June
The company might have vanquished delisting concerns with its surge.
Why Clovis Oncology Stock Is Taking a Step Backward Today
A key label expansion for the company's ovarian cancer drug could take longer than expected.
Why Clovis Oncology Stock Is Blasting Off Today
It reported some great initial data from one of its phase 1 clinical trials.
Valuation
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.